share_log

Jefferies Financial Group Analysts Boost Earnings Estimates for Symrise AG (OTCMKTS:SYIEY)

Jefferies Financial Group Analysts Boost Earnings Estimates for Symrise AG (OTCMKTS:SYIEY)

傑富瑞金融集團分析師上調SymriseAG(場外交易代碼:SYIEY)的收益預期
Defense World ·  2022/09/16 01:42

Symrise AG (OTCMKTS:SYIEY – Get Rating) – Research analysts at Jefferies Financial Group lifted their FY2024 earnings per share (EPS) estimates for Symrise in a note issued to investors on Wednesday, September 14th. Jefferies Financial Group analyst C. Counihan now expects that the company will post earnings per share of $1.16 for the year, up from their prior forecast of $1.12. The consensus estimate for Symrise's current full-year earnings is $0.82 per share. Jefferies Financial Group also issued estimates for Symrise's FY2025 earnings at $1.28 EPS.

SYRISE AG(OTCMKTS:SYIEY-GET Rating)-傑富瑞金融集團的研究分析師在9月14日星期三發佈的一份給投資者的報告中上調了他們對SymRise 2024財年每股收益(EPS)的預期。傑富瑞金融集團分析師C.Counihan現在預計,該公司今年的每股收益將為1.16美元,高於此前預測的1.12美元。對塞姆羅斯目前全年收益的普遍預期是每股0.82美元。傑富瑞金融集團還發布了對Symrose 2025財年每股收益的估計為1.28美元。

Get
到達
Symrise
塞姆瑞斯
alerts:
警報:

Separately, Berenberg Bank reduced their price objective on shares of Symrise from €119.00 ($121.43) to €114.00 ($116.33) and set a "hold" rating on the stock in a research note on Tuesday, July 19th. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average price target of $117.00.

另外,貝倫貝格銀行將其股票目標價從119.00歐元(121.43美元)下調至114.00歐元(116.33美元),並在7月19日(星期二)的一份研究報告中對該公司股票設定了“持有”評級。四位投資分析師對該股的評級為持有,一位分析師對該公司股票的評級為買入。根據MarketBeat的數據,該公司目前的平均評級為持有,平均目標價為117.00美元。

Symrise Stock Down 1.5 %

Symrise股下跌1.5%

Shares of SYIEY stock opened at $24.86 on Thursday. The business's 50 day simple moving average is $27.28 and its 200 day simple moving average is $27.84. The company has a current ratio of 2.04, a quick ratio of 1.17 and a debt-to-equity ratio of 0.41. Symrise has a one year low of $24.63 and a one year high of $37.21.
SYIEY股票週四開盤報24.86美元。該業務的50日簡單移動均線切入位為27.28美元,200日簡單移動均線切入位為27.84美元。該公司的流動比率為2.04,速動比率為1.17,債務權益比率為0.41。SymRise的一年低點為24.63美元,一年高位為37.21美元。

Symrise Company Profile

Symrise公司簡介

(Get Rating)

(獲取評級)

Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients. It operates through two segments, Taste, Nutrition & Health, and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and flavor solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for aqua feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods.

SYMROSE AG提供香料、調味品、化粧品活性成分和原材料以及功能成分。它通過味覺、營養與健康和氣味與護理兩個部分進行運作。味覺、營養和健康部門提供用於食品和飲料生產的功能性配料和風味解決方案;調味料;用於食品和飲料製造商、嬰兒食品和膳食補充劑的天然和可持續的配料;為寵物食品製造商提供的產品解決方案和服務;為水產飼料製造商開發魚和蝦養殖場解決方案的可持續配料和服務;以及用於食品補充劑和功能食品的益生菌。

See Also

另請參閲

  • Get a free copy of the StockNews.com research report on Symrise (SYIEY)
  • Is There a Cure for What is Ailing Teladoc Stock?
  • No One Told These 3 Stocks It's a Down Week
  • Why Medical Products Maker Repligen May Be A Potential Buy
  • At 10%, Is Arbor Realty Trust Dividend Worth It?
  • Investors Should Tune Into RF Industries
  • 免費獲取StockNews.com關於SYRESS的研究報告(SYIEY)
  • 有什麼辦法可以治癒Teladoc股票的問題嗎?
  • 沒有人告訴這三隻股票這是下跌的一週
  • 為什麼醫療產品製造商Repligen可能成為潛在收購對象
  • 在10%的水平上,Arbor Realty Trust的股息值得嗎?
  • 投資者應關注RF Industries

Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.

接受《SymriseDaily》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收最新新聞和分析師對Symrose及相關公司評級的每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論